wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q52567954-8C6B2939-5758-4480-AE4F-A025CA700637
Q52567954-8C6B2939-5758-4480-AE4F-A025CA700637
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52567954-8C6B2939-5758-4480-AE4F-A025CA700637
Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making.
P2860
Q52567954-8C6B2939-5758-4480-AE4F-A025CA700637
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52567954-8C6B2939-5758-4480-AE4F-A025CA700637
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e9ccef067bab34550e2ec9afb4b95f5e9c407e76
P2860
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.